Aubin Balmer
University of Lausanne
72 Papers
342 Citations
Aubin Balmer is an academic researcher from University of Lausanne. The author has contributed to research in topics: Retinoblastoma & Medicine. The author has an hindex of 22, co-authored 72 publications.
Chat about Author
Papers
Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications
Francis L. Munier,Marie-Claire Gaillard,Aubin Balmer,Sameh E. Soliman,Gregory Podilsky,Alexandre Moulin,Maja Beck-Popovic +6 more
TL;DR: Despite a possible confounding effect of concomitant chemotherapy prescription using other routes of administration in four of the successfully treated eyes, IViC achieved an unprecedented success rate of tumour control in the presence of vitreous seeding.
357
Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track
Francis L. Munier,Sameh E. Soliman,Alexandre Moulin,Marie-Claire Gaillard,Aubin Balmer,Maja Beck-Popovic +5 more
TL;DR: This technique is potentially safe and effective at a low cost and may play a promising role, especially in the treatment of recurrent and/or resistant vitreous disease in retinoblastoma, as an alternative to enucleation and/ or external beam radiotherapy.
199
Diagnosis and current management of retinoblastoma.
TL;DR: Retinoblastoma represents the prototypic model for inherited cancers and the heritable form, however, carries a high risk of second nonocular tumors and the prognosis for ocular function and even survival is jeopardized.
159
Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
Francis L. Munier,Maja Beck-Popovic,Aubin Balmer,Marie-Claire Gaillard,Etienne H. Bovey,Stefano Binaghi +5 more
TL;DR: It is suggested that SOAC should be given in one eye only and restricted to advanced cases of retinoblastoma, as an alternative to enucleation and/or external beam radiotherapy.
131
Metastatic melanoma in the eye and orbit.
Leonidas Zografos,Nicolas Ducrey,Donata Beati,Ann Schalenbourg,Barbara Spahn,Aubin Balmer,Chantal Bornet Othenin-Girard,Line Chamot,E. Egger +8 more
TL;DR: Metastatic melanomas to the eye and orbit are rare and generally occur in patients with disseminated metastases during the terminal stages of the disease, with a short life expectancy.
85